Literature DB >> 21448151

The bone marrow stroma in hematological neoplasms--a guilty bystander.

Claudio Tripodo1, Sabina Sangaletti, Pier P Piccaluga, Sonam Prakash, Giovanni Franco, Ivan Borrello, Attilio Orazi, Mario P Colombo, Stefano A Pileri.   

Abstract

In the setting of hematological neoplasms, changes in the bone marrow (BM) stroma might arise from pressure exerted by the neoplastic clone in shaping a supportive microenvironment, or from chronic perturbation of the BM homeostasis. Under such conditions, alterations in the composition of the BM stroma can be profound, and could emerge as relevant prognostic factors. In this Review, we delineate the multifaceted contribution of the BM stroma to the pathobiology of several hematological neoplasms, and discuss the impact of stromal modifications on the natural course of these diseases. Specifically, we highlight the involvement of BM stromal components in lymphoid and myeloid malignancies, and present the most relevant processes responsible for remodeling the BM stroma. The role of bystander BM stromal elements in the setting of hematological neoplasms is discussed, strengthening the rationale for treatment strategies that target the BM stroma.

Entities:  

Mesh:

Year:  2011        PMID: 21448151      PMCID: PMC3673297          DOI: 10.1038/nrclinonc.2011.31

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  132 in total

1.  Dysfunctional T regulatory cells in multiple myeloma.

Authors:  Rao H Prabhala; Paola Neri; Jooeun E Bae; Pierfrancesco Tassone; Masood A Shammas; Charles K Allam; John F Daley; Dharminder Chauhan; Elizabeth Blanchard; Hemant S Thatte; Kenneth C Anderson; Nikhil C Munshi
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Effects of allogeneic bone marrow-derived mesenchymal stem cells on T and B lymphocytes from BXSB mice.

Authors:  Weimin Deng; Qin Han; Lianming Liao; Shengguo You; Hongye Deng; Robert C H Zhao
Journal:  DNA Cell Biol       Date:  2005-07       Impact factor: 3.311

3.  Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.

Authors:  F Wu; Y Oka; A Tsuboi; O A Elisseeva; K Ogata; H Nakajima; F Fujiki; T Masuda; M Murakami; S Yoshihara; K Ikegame; N Hosen; M Kawakami; M Nakagawa; T Kubota; T Soma; T Yamagami; M Tsukaguchi; H Ogawa; Y Oji; T Hamaoka; I Kawase; H Sugiyama
Journal:  Leukemia       Date:  2005-02       Impact factor: 11.528

4.  CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.

Authors:  Antonella Zucchetto; Dania Benedetti; Claudio Tripodo; Riccardo Bomben; Michele Dal Bo; Daniela Marconi; Fleur Bossi; Debora Lorenzon; Massimo Degan; Francesca Maria Rossi; Davide Rossi; Pietro Bulian; Vito Franco; Giovanni Del Poeta; Silvia Deaglio; Gianluca Gaidano; Francesco Tedesco; Fabio Malavasi; Valter Gattei
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

Review 5.  The role of Dickkopf-1 in bone development, homeostasis, and disease.

Authors:  Joseph J Pinzone; Brett M Hall; Nanda K Thudi; Martin Vonau; Ya-Wei Qiang; Thomas J Rosol; John D Shaughnessy
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

Review 6.  Signaling pathways governing stem-cell fate.

Authors:  Ulrika Blank; Göran Karlsson; Stefan Karlsson
Journal:  Blood       Date:  2007-10-03       Impact factor: 22.113

Review 7.  The pathogenesis of the bone disease of multiple myeloma.

Authors:  Claire M Edwards; Junling Zhuang; Gregory R Mundy
Journal:  Bone       Date:  2008-02-21       Impact factor: 4.398

Review 8.  Thrombopoietin, HSCs, and the osteoblast niche: holding on loosely, but not letting G0.

Authors:  Stephen G Emerson
Journal:  Cell Stem Cell       Date:  2007-12-13       Impact factor: 24.633

9.  Increased frequency and suppression by regulatory T cells in patients with acute myelogenous leukemia.

Authors:  Miroslaw J Szczepanski; Marta Szajnik; Malgorzata Czystowska; Magis Mandapathil; Laura Strauss; Ann Welsh; Kenneth A Foon; Theresa L Whiteside; Michael Boyiadzis
Journal:  Clin Cancer Res       Date:  2009-05-05       Impact factor: 12.531

10.  Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment.

Authors:  Olaia Naveiras; Valentina Nardi; Pamela L Wenzel; Peter V Hauschka; Frederic Fahey; George Q Daley
Journal:  Nature       Date:  2009-06-10       Impact factor: 49.962

View more
  15 in total

1.  SPARC oppositely regulates inflammation and fibrosis in bleomycin-induced lung damage.

Authors:  Sabina Sangaletti; Claudio Tripodo; Barbara Cappetti; Patrizia Casalini; Claudia Chiodoni; Silvia Piconese; Alessandra Santangelo; Mariella Parenza; Ivano Arioli; Silvia Miotti; Mario P Colombo
Journal:  Am J Pathol       Date:  2011-10-11       Impact factor: 4.307

2.  In vivo RNAi screening identifies Pafah1b3 as a target for combination therapy with TKIs in BCR-ABL1+ BCP-ALL.

Authors:  Eleanor R C Fiedler; Arjun Bhutkar; Emily Lawler; Rana Besada; Michael T Hemann
Journal:  Blood Adv       Date:  2018-06-12

3.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts.

Authors:  Jerome Paggetti; Franziska Haderk; Martina Seiffert; Bassam Janji; Ute Distler; Wim Ammerlaan; Yeoun Jin Kim; Julien Adam; Peter Lichter; Eric Solary; Guy Berchem; Etienne Moussay
Journal:  Blood       Date:  2015-06-22       Impact factor: 22.113

4.  SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis.

Authors:  Giuseppe Visani; Maria Rosaria Sapienza; Alessandro Isidori; Claudio Tripodo; Maria Antonella Laginestra; Simona Righi; Carlo A Sagramoso Sacchetti; Anna Gazzola; Claudia Mannu; Maura Rossi; Michele De Nictolis; Massimo Valentini; Meris Donati; Roberto Emiliani; Francesco Alesiani; Stefania Paolini; Carlo Finelli; Stefano A Pileri; Pier Paolo Piccaluga
Journal:  PLoS One       Date:  2011-11-14       Impact factor: 3.240

5.  Microenvironment-centred dynamics in aggressive B-cell lymphomas.

Authors:  Matilde Cacciatore; Carla Guarnotta; Marco Calvaruso; Sabina Sangaletti; Ada Maria Florena; Vito Franco; Mario Paolo Colombo; Claudio Tripodo
Journal:  Adv Hematol       Date:  2012-02-19

6.  Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia.

Authors:  Eric Tran; Dhanalakshmi Chinnasamy; Zhiya Yu; Richard A Morgan; Chyi-Chia Richard Lee; Nicholas P Restifo; Steven A Rosenberg
Journal:  J Exp Med       Date:  2013-05-27       Impact factor: 14.307

7.  Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.

Authors:  Sabina Sangaletti; Claudio Tripodo; Paola Portararo; Matteo Dugo; Caterina Vitali; Laura Botti; Carla Guarnotta; Barbara Cappetti; Alessandro Gulino; Ilaria Torselli; Patrizia Casalini; Claudia Chiodoni; Mario P Colombo
Journal:  Oncoimmunology       Date:  2014-06-05       Impact factor: 8.110

8.  Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization.

Authors:  Hanwen Zhang; Wenbin Zhang; Xuan Sun; Ruoyu Dang; Rongmei Zhou; Hui Bai; Jingjing Ben; Xudong Zhu; Yan Zhang; Qing Yang; Yong Xu; Qi Chen
Journal:  Oncotarget       Date:  2016-08-02

9.  CXCL12/CXCR4 pathway is activated by oncogenic JAK2 in a PI3K-dependent manner.

Authors:  Hadjer Abdelouahab; Yanyan Zhang; Monika Wittner; Shinya Oishi; Nobutaka Fujii; Rodolphe Besancenot; Isabelle Plo; Vincent Ribrag; Eric Solary; William Vainchenker; Giovanni Barosi; Fawzia Louache
Journal:  Oncotarget       Date:  2016-07-22

Review 10.  Stem cells and bone diseases: new tools, new perspective.

Authors:  Mara Riminucci; Cristina Remoli; Pamela G Robey; Paolo Bianco
Journal:  Bone       Date:  2014-09-18       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.